Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients
B. K.M. Reddy, V. Lokesh, M. S. Vidyasagar, K. Shenoy, K. G. Babu, A. Shenoy, T. Naveen, Bindhu Joseph, R. Bonanthaya, Nanjundappa, P. P. Bapsy, Loknatha, Jayarama Shetty, Krishna Prasad, C. R. Tanvir Pasha
Dive into the research topics of 'Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients'. Together they form a unique fingerprint.